Nvidia announces partnership with Britain's GSK for drug, vaccine discovery


SAN FRANCISCO, Oct. 5 (Xinhua) -- U.S. computer giant Nvidia Corporation on Monday announced a partnership with global healthcare company GSK and its AI group, which is applying computation to drug and vaccine discovery process.

According to Nvidia, GSK has recently established a new London-based AI hub, which will leverage GSK's genetic and genomic data to improve the process of designing and developing transformational medicines and vaccines.

GSK's hub will utilize biomedical data, AI methods and advanced computing platforms to unlock genetic and clinical data.

The GSK AI hub, once fully operational, will be home to its Britain-based AI team, including GSK AI Fellows, a new professional training program and now scientists from Nvidia, the company said.

GSK will have access to Nvidia's Cambridge-1, Britain's most powerful AI supercomputer, also announced Monday by Nvidia.

"Because of the massive size of the datasets we use for drug discovery, we need to push the boundaries of hardware and develop new machine learning software," said Kim Branson, senior vice president at GSK.

"GSK and Nvidia together will help push the boundaries of what AI can do and put vast data sources to work to advance the discovery of new medicines and vaccines," said Kimberly Powell, vice president of healthcare at Nvidia.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

Next In World

Pakistan gives U.N. a dossier on India after India submits one on Pakistan
Canada sees daily average of 5,050 COVID-19 cases over past week
Uruguay to step up COVID-19 testing
Syria says Israel hits southern Damascus area in second strike in week
White House approves intelligence brief for Biden
Roundup: France's Macron unveils gradual easing of lockdown, expecting "new stage"
China will secure economic recovery with right mix of policies: IMF chief
Plasma from recovered patients shows little benefit in those hospitalized with COVID-19 - study
Biden says UK border with Ireland must be open
U.S.-listed Chinese firms trade mostly higher

Stories You'll Enjoy